Animal Models in Biomedical Research: Ethics and Alternatives
DOI:
https://doi.org/10.55544/sjmars.4.3.3Keywords:
Bioethics, Animal Testing, 3Rs Principle, In Vitro Alternatives, Biomedical ModelsAbstract
Animal models have long been central to biomedical research, providing critical insights into disease mechanisms, pharmacological responses, and therapeutic outcomes. However, the ethical concerns surrounding animal experimentation have grown substantially, leading to debates over the necessity, justification, and humane treatment of animals in laboratories. This paper explores the role of animal models in modern biomedical science, scrutinizes ethical concerns, and evaluates emerging alternatives such as organoids, computer simulations, and in vitro systems. The study emphasizes the importance of adhering to the 3Rs principle—Replacement, Reduction, and Refinement—and assesses current global trends aimed at replacing animal models with more humane and technologically advanced methods.
References
[1] Akhtar, A. (2015). The flaws and human harms of animal experimentation. Cambridge Quarterly of Healthcare Ethics, 24(4), 407–419.
[2] European Commission. (2020). Directive 2010/63/EU on the protection of animals used for scientific purposes.
[3] Hartung, T. (2021). New approach methodologies: New challenges for toxicology. Frontiers in Toxicology, 3, 673620.
[4] Mak, I. W. Y., Evaniew, N., & Ghert, M. (2014). Lost in translation: animal models and clinical trials in cancer treatment. American Journal of Translational Research, 6(2), 114–118.
[5] Pound, P., & Bracken, M. B. (2014). Is animal research sufficiently evidence based to be a cornerstone of biomedical research? BMJ, 348, g3387.
[6] Regan, T. (2004). The Case for Animal Rights. University of California Press.
[7] Russell, W. M. S., & Burch, R. L. (1959). The Principles of Humane Experimental Technique. Methuen.
[8] Singer, P. (1975). Animal Liberation. New York Review.
[9] Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4), 663–676.
[10] van der Worp, H. B., et al. (2010). Can animal models of disease reliably inform human studies? PLoS Medicine, 7(3), e1000245.
[11] Bailey, J. (2020). The illusion of protection: An analysis of animal-based drug testing. Alternatives to Laboratory Animals, 48(1), 21–33.
[12] British Pharmacological Society. (2021). Training and Education in the Use of Alternatives to Animals in Biomedical Research.
[13] Cruelty Free International. (2022). Global ban on cosmetic animal testing: Current progress.
[14] Ekins, S., Puhl, A. C., & Zorn, K. M. (2019). Exploiting machine learning for in silico toxicity prediction. Drug Discovery Today, 24(2), 635–641.
[15] European Commission. (2022). Directive 2010/63/EU on the protection of animals used for scientific purposes.
[16] FDA. (2022). FDA Modernization Act 2.0.
[17] Hackam, D. G., & Redelmeier, D. A. (2006). Translation of research evidence from animals to humans. JAMA, 296(14), 1731–1732.
[18] Huh, D., et al. (2010). Reconstituting organ-level lung functions on a chip. Science, 328(5986), 1662–1668.
[19] Lancaster, M. A., et al. (2013). Cerebral organoids model human brain development and microcephaly. Nature, 501(7467), 373–379.
[20] Lanzoni, G., et al. (2022). Bridging the gap: Integrated use of animal and alternative models in translational medicine. Translational Medicine Communications, 7(1), 14–22.
[21] Mak, I. W., Evaniew, N., & Ghert, M. (2014). Lost in translation: Animal models and clinical trials in cancer treatment. American Journal of Translational Research, 6(2), 114–118.
[22] MoEFCC. (2021). CPCSEA Guidelines on Laboratory Animal Ethics. Ministry of Environment, Forest and Climate Change, India.
[23] NC3Rs. (2020). The 3Rs: Replacement, Reduction and Refinement.
[24] Perlman, R. L. (2016). Mouse models of human disease. ILAR Journal, 57(1), 117–128.
[25] Pound, P., & Bracken, M. B. (2014). Is animal research sufficiently evidence based to be a cornerstone of biomedical research? BMJ, 348, g3387.
[26] Russell, W. M. S., & Burch, R. L. (1959). The Principles of Humane Experimental Technique.
[27] Takebe, T., et al. (2017). Vascularized and complex organ buds from diverse tissues via mesenchymal cell-driven condensation. Cell Stem Cell, 21(3), 456–472.
[28] van der Naald, M., et al. (2022). The implementation gap in animal research ethics: Evidence from Dutch laboratories. Animals, 12(1), 88.
[29] Zhang, B., et al. (2023). Multi-organ-on-a-chip: New frontiers in disease modeling and drug testing. Advanced Drug Delivery Reviews, 198, 113899.
[30] Bailey, J., Thew, M., & Balls, M. (2014). An Analysis of the Use of Animal Models in Predicting Human Toxicology and Drug Safety. ATLA, 42(3), 181–199.
[31] Bhatia, S. N., & Ingber, D. E. (2014). Microfluidic organs-on-chips. Nature Biotechnology, 32(8), 760–772.
[32] Ewart, L. et al. (2018). Use of Microphysiological Systems in Drug Development and Regulatory Science. Toxicology Research and Application, 2, 239784731878906.
[33] Gupta, D., & Kohli, K. (2020). Regulatory Approaches to Animal Testing in India: The Role of CPCSEA. Indian Journal of Pharmacology, 52(4), 258–262.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Stallion Journal for Multidisciplinary Associated Research Studies
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
10.55544/sjmars
editor@sjmars.com | 
+91-8874396939
